Skip Navigation

Strengthen the Evidence for Maternal and Child Health Programs

Sign up for MCHalert eNewsletter

Search Results: MCHLine

Items in this list may be obtained from the sources cited. Contact information reflects the most current data about the source that has been provided to the MCH Digital Library.

Displaying records 1 through 8 (8 total).

Barzel R, Holt K, Kolo S. 2022. Opioids and pregnant women: Information for oral health professionals. Washington, DC: National Maternal and Child Oral Health Resource Center, 4 pp.

Annotation: This practice guidance provides an overview of pain management for dental procedures for women of reproductive age. It discusses pharmacological considerations for pregnant women (pharmaceutical agents and indications, contraindications, and special considerations), neonatal opioid withdrawal syndrome, guidelines for providing opioids, managing acute dental pain, and guidelines for discharging women with opioid prescriptions. Information about prescription drug monitoring programs is included. [Funded by the Maternal and Child Health Bureau]

Contact: National Maternal and Child Oral Health Resource Center, Georgetown University, Washington, DC 20057, E-mail: [email protected] Web Site: https://www.mchoralhealth.org Available from the website.

Keywords: Drug addiction, Guidelines, Narcotics, Neonatal abstinence syndrome, Oral health, Pain relieving drugs, Pregnant women, Prescription drugs

National Institute for Health Care Management Foundation. 2015. Reducing neonatal abstinence syndrome in Tennessee. Washington, DC: National Institute for Health Care Management Foundation, 2 pp. (Women, children & adolescents)

Annotation: This fact sheet highlights partnerships to address the neonatal abstinence syndrome (NAS) epidemic in Tennessee. Topics include efforts to expand a community-based program to assist mothers with substance abuse problems and ensure a drug-free and safe home for their newborns; provide start-up costs for a regional detox center for women addicted to prescription drugs; research the effectiveness of detox from opiate drugs during pregnancy, and the long-term effect of detox treatment on NAS rates in the state; and establish a hospital-based NAS treatment process.

Contact: National Institute for Health Care Management Foundation, 1225 19th Street, N.W., Suite 710, Washington, DC 20036, Telephone: (202) 296-4426 Fax: (202) 296-4319 E-mail: http://www.nihcm.org/contact Web Site: http://www.nihcm.org Available from the website.

Keywords: Drug addiction, Drug use during pregnancy, Financing, Neonatal abstinence syndrome, Newborn infants, Opiates, Postpartum care, Pregnant women, Prenatal care, Prevention program, State initiatives, Substance abuse treatment, Tennessee

Ramakrishnan M. 2014. Neonatal abstinence syndrome: How states can help advance the knowledge base for primary prevention and best practices of care. Arlington, VA: Association of State and Territorial Health Officials, 24 pp.

Annotation: This report describes opportunities to avert or ameliorate the outcome of neonatal abstinence syndrome (NAS) along a continuum of care spanning timeframes in the mother's and infant's life and the role of state health agencies. Topics include surveillance for NAS-affected infants and the sources of maternal opiate use; reimbursement for using screening protocols to detect substance abuse early in pregnancy and withdrawal signs in newborns; development of measures to ensure follow-up with opioid-dependent women and receipt of comprehensive services; and collaborative efforts to strengthen clinical standards for identification, management, and follow-up with NAS-affected infants and their families. A state index of resources is included.

Contact: Association of State and Territorial Health Officials, 2231 Crystal Drive, Suite 450, Arlington, VA 22202, Telephone: (202) 371-9090 Fax: (571) 527-3189 Web Site: http://www.astho.org Available from the website.

Keywords: Comprehensive health care, Intervention, Neonatal abstinence syndrome, Neonatal addiction, Newborn infants, Opiates, Population surveillance, Primary prevention, Screening, State health agencies, Substance use

National Institute for Health Care Management Foundation and Association of State and Territorial Health Officials. 2014. Neonatal abstinence syndrome: Strategies for states and health plans. Washington, DC: National Institute for Health Care Management Foundation, multiple items.

Annotation: These resources, from a webinar held on July 16, 2014, highlight strategies for preventing and treating neonatal abstinence syndrome (NAS). Contents include a recording of the speaker's presentations (1 hour, 27 min., 23 sec.), the webinar agenda and speaker biographies, and related materials. Topics include recent trends in opioid abuse and NAS, with an overview of federally-led prevention efforts; the impact of rising NAS rates across the states, including implications for Medicaid and examples of state-level action; a health plan-led initiative to improve care coordination and social support for pregnant women in treatment for addiction; and the latest in NAS treatment, and an assessment of where public and private investments would be most beneficial.

Contact: National Institute for Health Care Management Foundation, 1225 19th Street, N.W., Suite 710, Washington, DC 20036, Telephone: (202) 296-4426 Fax: (202) 296-4319 E-mail: http://www.nihcm.org/contact Web Site: http://www.nihcm.org Available from the website.

Keywords: Analgesic drugs, Collaboration, Drug addiction, Drug effects, Federal initiatives, Health care systems, Model programs, Neonatal abstinence syndrome, Newborns, Opiates, Pregnant women, Prevention programs, Public private partnerships, State MCH programs, Substance abuse treatment

Wenzel S, Kosofsky BE, Harvey JA, Iguchi MY, Steinberg P, Watkins KE, Shaikh R. 2001. Prenatal cocaine exposure: Scientific considerations and policy implications. Santa Monica, CA: Rand , 39 pp.

Annotation: This report presents an overview of the current state of knowledge regarding the effects of cocaine on the developing brain of the fetus and offers policy considerations for addressing the issues that arise from cocaine use by pregnant women. Three preventive strategies are outlined; primary (before and during pregnancy), secondary (to identify pregnant women who use drug and minimizing their drug use), and tertiary (to reduce the adverse consequences of substance exposure to children exposed in utero). The report also includes additional sources, and references.

Contact: Rand Corporation, 1776 Main Street, Santa Monica, CA 90407-3208, Telephone: (310) 393-0411 Fax: 310-393-4818 E-mail: [email protected] Web Site: http://www.rand.org $10.00, plus shipping and handling; also available from the website. Document Number: ISBN 0-8330-3001-9.

Keywords: Cocaine, Drug affected infants, Drug use during pregnancy, Fetal development, Neonatal addiction, Substance abuse prevention programs, Substance abusing pregnant women

U.S. Department of Health and Human Services, Office of Inspector General, Office of Evaluation and Inspections. 1990. Crack babies. Washington, DC: U.S. Department of Health and Human Services, Office of Evaluation and Inspections, 38 pp.

Annotation: This report examines how crack babies are affecting the child welfare in 12 major metropolitan areas. The report is based on on-site interviews conducted during the last quarter of 1989 and a review of studies and public documents on the subject. Recommendations for state, local and federal actions are included.

Contact: U.S. Department of Health and Human Services, Office of Inspector General, c/o U.S. Department of Health and Human Services, Office of Public Affairs, Cohen Building, Room 5541, 330 Independence Avenue, S.W., Washington, DC 20201, Telephone: (202) 619-1343 Fax: (202) 260-8512 E-mail: [email protected] Web Site: https://oig.hhs.gov Available from the website. Document Number: OEI-03-89-01540.

Keywords: Child welfare, Drug affected infants, Neonatal addiction, Substance abuse

U.S. Department of Health and Human Services, Office of Inspector General. 1990. Crack babies: Selected model practices. Washington, DC: U.S. Department of Health and Human Services, 16 pp.

Annotation: This report describes selected model practices which may be effective in assisting drug-exposed babies and their families. The programs were identified during an inspection examining how crack babies affect the child welfare system. Model programs and practices used by public and private agencies and state and local governments to address the many service problems for this population are presented in eight categories: community outreach and early intervention, comprehensive services in one location, education for drug-exposed children, case management, professional training, management practices, interagency coordination, and private initiatives.

Contact: U.S. Department of Health and Human Services, Office of Inspector General, c/o U.S. Department of Health and Human Services, Office of Public Affairs, Cohen Building, Room 5541, 330 Independence Avenue, S.W., Washington, DC 20201, Telephone: (202) 619-1343 Fax: (202) 260-8512 E-mail: [email protected] Web Site: https://oig.hhs.gov Available from the website. Document Number: OEI-03-89-01542.

Keywords: Child welfare, Drug affected infants, Neonatal addiction, Substance abuse

Ferguson P, Lennox T, eds. 1974. Drugs and pregnancy: The effects of nonmedical use of drugs on pregnancy, childbirth, and neonates. Rockville, MD: National Institute on Drug Abuse; Washington, DC: for sale by U.S. Government Printing Office, 147 pp. (Research issues series; no. 5)

Annotation: This book summarizes major research findings regarding drug use and abuse during pregnancy and their effect on neonates. Nonmedical drugs covered include LSD, heroin and methadone.

Contact: U.S. Government Publishing Office, 732 North Capitol Street, N.W., Washington, DC 20401, Telephone: (202) 512-1800 Secondary Telephone: (866) 512-1800 Fax: (202) 512-2104 E-mail: [email protected] Web Site: http://www.gpo.gov Available in libraries. Document Number: DHEW (ADM) 76-187.

Keywords: Drug abuse, Neonatal addiction, Pregnancy
   

This project is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) under grant number U02MC31613, MCH Advanced Education Policy, $3.5 M. This information or content and conclusions are those of the author and should not be construed as the official position or policy of, nor should any endorsements be inferred by HRSA, HHS or the U.S. Government.